ArticleJournal of translational medicine2024

MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling.

Jin-Sil Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.